America’s pharmaceutical research and biotechnology companies are developing 34 medicines for diseases that disproportionately affect American women. The new report, Medicines in Development for Women, is presented by the Pharmaceutical Research and Manufacturers of America in cooperation with Prevent Blindness America and other national health organizations.
In addition to glaucoma and dry eye medicines in development, the report lists 155 medicines in development for diabetes, also a major cause of vision loss for women.
Treatment of age-related eye diseases, including glaucoma and diabetic eye disease, costs $51.4 billion annually.
For the full report, please visit www.phrma.org.
For more information on Prevent Blindness, please visit www.pbga.org.
No comments:
Post a Comment